News Releases:
-
06/30/09
-
06/30/09
-
06/19/09
Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
-
06/10/09
-
06/01/09
-
05/22/09
-
05/21/09
-
05/20/09
Cephalon Acquires Controlling Interest in Arana Therapeutics
-
05/20/09
-
05/05/09
Cephalon Reports Strong Sales and Earnings for the First Quarter 2009
-
04/06/09
Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
-
03/31/09
-
03/17/09
Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
-
02/27/09
Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics
-
02/12/09
-
02/04/09
-
02/02/09
Cephalon Exercises Option to License Worldwide Rights to ImmuPharma Product, Lupuzor
-
01/13/09
Cephalon Signs Option Agreement to Acquire Ception Therapeutics
-
01/12/09
-
01/08/09
Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference
Cephalon Quarterly Conference Call Invitation
06/30/09
Second Quarter 2009 Earnings Conference Call Tuesday, August 4, 2009, 5:00 p.m. U.S. EDT
FRAZER, Pa., June 30, 2009 /PRNewswire-FirstCall via COMTEX/ -- Cephalon, Inc. (Nasdaq: CEPH) has scheduled its regular quarterly earnings conference call covering second quarter 2009 results for 5:00 p.m. EDT on Tuesday, August 4, 2009.
August 4, 2009 Schedule
4:10 p.m. EDT -- Q2 2009 results will be distributed by PRNewswire
4:50 p.m. EDT -- To participate in the conference call, dial 913-312-0379 and refer to Conference Code Number 1696714
5:00 p.m. EDT -- Conference call begins promptly.
Simultaneous Webcast
Investors can listen to the call live by logging on to the company's website at www.cephalon.com and clicking on the "Investors" tab then "Webcast." Please click on the link and follow the prompts for registration and access.
If you are unable to listen to the live broadcast, an audio or webcast replay of the call will be available approximately two hours after the event until Midnight EDT, August 11, 2009. To listen to the audio replay, dial 719-457-0820 and use the Conference Code Number 1696714.
Additional information presented on the conference call may be made available on the Investor page of the company's website.
Contact: Robert S. (Chip) Merritt
610-738-6376
cmerritt@cephalon.com
SOURCE Cephalon, Inc.